Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 28, 2017- First targeted biologic in the European Union to receive marketing authorization for use in atopic dermatitis -
-
Sep 16, 2017- Late-breaking oral abstract of Phase 3 CAFÉ study presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress -
-
Jun 11, 2017- Data presented at the 77th Scientific Sessions of the American Diabetes Association (ADA) -
-
Jun 4, 2017- Oral presentation provides first REGN2810 data in patients with advanced cutaneous squamous cell carcinoma (CSCC) -
-
May 22, 2017- Kevzara is now available to U.S. patients -
-
May 11, 2017-- New Initiative Encourages Americans to Help Reduce Air Pollution & Enjoy the Outdoors this Spring Allergy Season --
-
Apr 28, 2017- New action date for Kevzara U.S. BLA is May 22, 2017 -
-
Apr 25, 2017- Monthly dosing schedule now approved in both United States and European Union -